ISPE

OCTOBER 25, 2022

Throughout her early career, she successfully led multiple biotech, vaccine, and API processes from late-stage research and development to clinical and commercial manufacturing. She also worked on design and CQV projects of all sizes and provided business solutions to spearhead expansion of NNE and ADVENT.

Vaccines 98

Vaccines 98

European Pharmaceutical Review

FEBRUARY 27, 2024

In 2012, Dame June was elected as the first chair of the European Pharmacovigilance Risk Assessment Committee, MHRA added. While she is stepping down from her current role, Dame June shared that she still hopes to contribute “to patient safety and public health in other ways.”

Communication 111

Communication Vaccines 111

pharmaphorum

JANUARY 5, 2023

It’s also an industry where technologists have recently made massive contributions, whether it’s getting COVID vaccines to market faster or making unprecedented advancements in predictive AI, like Chroma from Generate Biomedicines. Since co-founding Benchling in 2012, Ashu has overseen the company’s rapid growth. About the author.

Hospitals 105

Hospitals Vaccines 105

pharmaphorum

OCTOBER 12, 2022

Del Bourgo highlights that genomic treatments work in a similar way to mRNA, which has been used in COVID-19 vaccines. Just as mRNA and COVID-19 showed the world that it’s possible to develop vaccines much faster, Del Bourgo explains, AI can help us develop new genomic medicines in a more efficient way.

Immunization 105

Immunization Vaccines Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

SEPTEMBER 18, 2020

In June 2007, AstraZeneca completed the acquisition of vaccine maker MedImmune, buying its drug-development pipeline for $15.2 AstraZeneca was one of the top ten pharmaceutical companies in the world in 2012, but faced a string of patent expiries in its blockbuster drugs. Blockbusters go off patent. Pascal Soriot. A comeback story?

Pharmaceutical Companies 116

Pharmaceutical Companies Vaccines Pharmaceutical Companies FDA 116

ISPE

OCTOBER 28, 2022

Dr Gouws added that WHO was the only regulatory authority to have performed inspections of Chinese manufacturers of Covid-19 vaccines during the pandemic. Dr Gouws indicated that many of the Covid-19 vaccine manufacturers in India had also been inspected by WHO and a similar information sharing approach had been undertaken by WHO.

FDA 97

FDA Vaccines Documentation Dosage 97

Pharmaceutical Technology

MAY 26, 2023

While the market was worth over $6 billion in 2012, this has now grown to nearly $48 billion only a decade later, said Avigayil Chalk, PhD, GlobalData’s Senior Oncology and Haematology analyst, at an immuno-oncology webinar held on May 23. Checkpoint modulators are forecasted to retain the largest share of this, based on the webinar.

Immunization 105

Immunization Vaccines Compounding Insurance 105

pharmaphorum

JANUARY 19, 2023

He continued: “I think this is largely because, since 2012, the budget has been hugely skewed towards acute services […] Successive governments have raided the budget of the healthcare system. The vaccine programme is the best example,” Lord Prior said. The NHS is clearly a failing system.

Hospitals 95

Hospitals Vaccines 95

European Pharmaceutical Review

FEBRUARY 3, 2023

percent in 2012 to 3.2 This historically saw an average clawback rate of seven percent prior to the pandemic. Impact on the UK’s pharmaceutical industry The UK’s share of global pharmaceutical R&D has been declining over the past decade, falling from 4.9 percent in 2022, the industry body stated.

Vaccines 59

Vaccines 59

Hospital Pharmacy Europe

FEBRUARY 16, 2023

In fact, work from 2012 showed that the use of a TLR-2 agonist in mice offered protection against influenza. Given the important role of TLRs in the earliest phase of a host’s immune response, the development of TLR agonists is a promising therapeutic strategy.

Immunization 52

Immunization Hospitals Vaccines 52

pharmaphorum

OCTOBER 12, 2021

Belgium-born Stoffels has been CSO at J&J since 2012, and was global head of pharma R&D for three years before that whilst also serving as chairman of the pharma division between 2011 and 2015. He has also led J&J’s venture capital arm JJDC, and made open-ended innovation and partnering a key strategy for J&J.

Vaccines 52

Vaccines 52

PharmaShots

MARCH 14, 2023

The act includes drugs, vaccines, and therapeutics that are intended to treat a disease affecting <200,000 American citizens. UniQure’s Glybera is the first approved gene therapy by the EMA in the year 2012 for the treatment of a rare disease lipoprotein lipase deficiency.

FDA 40

FDA Immunization Compounding Vaccines 40

Blog: Ask a Student Pharmacist

AUGUST 23, 2023

197-217 SG Chou, AK Soper, S Khodadadi, JE Curtis, S Krueger, MT Cicerone, A Fitch, E Shalaev (2012). In : Lyophilized Biologics and Vaccines: Modality-Based Approaches. Hastedt, Eds, Drugs and the Pharmaceutical Sciences (2008), 175 (Protein Formulation and Delivery (2nd Edition)), pp.

Dosage 52

Dosage Vaccines 52

Pharmaceutical Technology

APRIL 20, 2023

1] Making the transition The number of decentralised clinical trials has steadily increased over the past decade, rising from 250 in 2012 to 1,291 in 2021. They are expected to peak even higher in 2022, with GlobalData forecasting the industry to hold approximately 1,425 DCTs by the end of the year. [2]

Vaccines 52

Vaccines 52

ISPE

SEPTEMBER 22, 2022

Paul Jansen from the company hosting the event in Boxmeer (MSD Animal Health) described the modular construction of an animal vaccine plant and shared opportunities and lessons learned. The ISPE Project Management CoP Benelux was founded in 2012. This event was sponsored by: Advirpo. Flow Technology.

Vaccines 52

Vaccines 52

ISPE

NOVEMBER 21, 2022

Dr Gouws added that WHO was the only regulatory authority to have performed inspections of Chinese manufacturers of Covid-19 vaccines during the pandemic. Dr Gouws indicated that many of the Covid-19 vaccine manufacturers in India had also been inspected by WHO and a similar information sharing approach had been undertaken by WHO.

FDA 52

FDA Vaccines Documentation Dosage 52

Pharmaceutical Technology

JANUARY 25, 2023

7,000 more clinical trials take place each year in the Asia-Pacific region compared with 2012, and 1,200 more in the Middle East and Africa. The global vaccine rollout would never have taken place without the advances in visibility and control over supply chains that it necessitated. The world of clinical trials is changing.

Pharmaceutical Companies 59

Pharmaceutical Companies Vaccines Pharmaceutical Companies Communication 59

PharmaShots

APRIL 25, 2023

Founded Year: 2012 Total Employees: ~190 Headquarters: California, United States Market Cap: $1.2B The company strives to discover and develop therapeutic products under its business segments, including General Medicines, Specialty Medicines, and Vaccines. Aligos is developing ALG‑125755 under its oligonucleotide platform.

HIV Treatment and Prevention Agents 40

HIV Treatment and Prevention Agents Packaging Immunization Vaccines 40

PharmaShots

APRIL 13, 2023

and became a leader in the medical device industry Novartis raised its sales by 16% and acquired Alcon (ophthalmic business), Genoptix (oncology business), and an 85% stake in Zhejiang Tianyuan (vaccine business) Bayer recorded a revenue of $49B as its pharmaceutical business posted an encouraging performance in the emerging market.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Labelling 40

Pharmaceutical Technology

JULY 23, 2008

With expensive new treatments, increasing numbers of patients in chemotherapy in major markets and developing nations like China, Brazil and Russia investing more in treating and diagnosing cancer, IMS predicts a compound growth rate of 12–15% and tips the global market to reach $80bn by 2012.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Compounding Chemotherapy 40

Pharmaceutical Technology

JANUARY 25, 2023

7,000 more clinical trials take place each year in the Asia-Pacific region compared with 2012, and 1,200 more in the Middle East and Africa. The global vaccine rollout would never have taken place without the advances in visibility and control over supply chains that it necessitated. The world of clinical trials is changing.

Pharmaceutical Companies 52

Pharmaceutical Companies Vaccines Pharmaceutical Companies Communication 52

ISPE

AUGUST 30, 2022

During the pandemic, the pharmaceutical industry faced challenges in the production of COVID-19 therapeutics and vaccines to meet global demand, as well as mitigation of drug shortages for non-COVID-19-related products, without compromising product quality or patient safety. Published May 2012. Published 2008.

Documentation 52

Documentation FDA Packaging Communication 52

PharmaShots

JANUARY 31, 2023

Founded Year: 2012 No. The Company's premier line of smart safety syringes, Sharps Provensa, prevents accidental needlestick injuries, prevents needle reuse, and minimizes drug and vaccine waste—all while maintaining the intuitive simplicity of conventional syringes. Funding Value: $11.4M of Shares: 1.4M Funding Value: $15.9M

Vaccines 40

Vaccines Immunization FDA 40

PharmaShots

FEBRUARY 20, 2023

Medicago, has a technology called Proficia through which the company has developed Covifenz, a plant based VLP, recombinant, adjuvanted vaccine for COVID-19 in collaboration with GSK 5. Different species of Solanaceae have capacities to produce heterologous proteins such as the E.

Vaccines 40

Vaccines Pharmaceutical Companies Pharmaceutical Companies Compounding 40

European Pharmaceutical Review

DECEMBER 14, 2023

Between 1999 and 2001, it supported 17 percent of withdrawals, between 2002 and 2011, it supported 26 percent of withdrawals and by 2012 to 2016, 80 percent of withdrawals were supported by observational studies (cohort, case-control, or other epidemiologic design). Meta-analyses contributed least frequently (31.4 Lane S, Lynn E, Shakir S.

Medical Records 116

Medical Records Vaccines Hospitals 116

pharmaphorum

FEBRUARY 26, 2021

In 2012, J&J agreed to pay US $181 million to 26 states in order to settle these claims – though another lawsuit related to the drug (for $8 billion, eventually reduced to $6.8 CEO Alex Gorsky, who was appointed in 2012. Risperdal is well-known due to the controversy in the US following its product launch in 1994.

Vaccines 126

Vaccines Labelling Communication 126

ISPE

MARCH 8, 2023

2 , 16 , 17 , 18 One example is the switching of tributyltin azide with sodium azide and dimethyl formamide by Zhejiang Huahai Pharmaceuticals (ZHP) in 2012 to reduce waste and to increase yield in the production of angiotensin II receptor blockers, resulting in the formation of N-nitrosodimethylamine (NDMA), a known carcinogenic impurity.

Compounding 52

Compounding Compounding Pharmacies Packaging FDA 52

The Checkup by Singlecare

JANUARY 12, 2023

Journal of Affective Disorders , 2012). A fear of needles ( trypanophobia) causes up to 16% of adults to avoid getting vaccines. Nearly 35% of a study of 1,001 patients with obsessive-compulsive disorder (OCD) also had a social phobia. Cleveland Clinic , 2022). Cleveland Clinic , 2022).

Vaccines 52

Vaccines 52

pharmaphorum

AUGUST 31, 2021

Roche’s Genentech unit bought into the programme in 2012 and amended it three years later. Along with semorinemab, the biotech has also partnered with Johnson & Johnson on a tau-targeting vaccine (ACI-35) and with Eli Lilly on a small-molecule tau aggregation inhibitor. AC Immune has a lot riding on the tau hypothesis.

Immunization 52

Immunization Labelling Vaccines 52

The People's Pharmacy

MAY 10, 2023

Studying Dog Owners: The study was conducted in Sweden between 2001 and 2012 and included more than 300,000 individuals who had experienced a stroke or a heart attack ( Circulation: Cardiovascular Quality and Outcomes , Oct. There are vaccines for canine influenza. Dogs can spread the virus between each other with close contact.

Vaccines 81

Vaccines 81

Pharmaceutical Technology

MAY 9, 2023

For Jamaels, whose track record in managing complex operations and delivering process improvements spans GSK Vaccines and one of the world’s largest companies, GE, the technological shift is an exciting development: “I’m passionate about the digital transformation that our industry is going through,” he says. of the global trial landscape.

Vaccines 52

Vaccines Process Improvement Communication 52

Pharmaceutical Technology

FEBRUARY 20, 2023

The two companies, along with Cerba Research’s specialty virology subsidiary Viroclinics-DDL, have had a long track record in collaborative projects since 2012, from specialty assay transfers to full clinical trial management and logistics support services. Teddy Lab also reached multiple milestones in the past 5 years.

Research Laboratories 52

Research Laboratories Vaccines Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

NOVEMBER 4, 2021

Routine vaccination with human papillomavirus vaccines have resulted in an 87% reduction in cervical cancer cases in England, and could even see the need for smear tests phased out in future, according to a new study. The first vaccine used was GlaxoSmithKline’s Cervarix, which was replaced by MSD’s Gardasil in 2012.

Vaccines 105

Vaccines 105

The Checkup by Singlecare

NOVEMBER 14, 2023

You can reduce your risk of HPV, which is the cause of almost all cervical cancers, by getting vaccinated with Gardasil 9. Sources Menstrual bleeding patterns among regularly menstruating women , American Journal of Epidemiology (2012) Trying to get pregnant? Cervical cancer screening should begin at age 21.

Hospitals 52

Hospitals Vaccines 52

European Pharmaceutical Review

DECEMBER 23, 2024

November 2012. Internet] Vaccines Europe. EMA/CHMP/ICH/214732/2007. ICH Q11 Development And Manufacture Of Drug Substances (Chemical Entities And Biotechnological/Biological Entities) – Scientific Guideline. EMA/CHMP/ICH/425213/2011. 4 March 2020. EMA/CHMP/ICH/804273/2017. J Pharm Sci. 2024; 113: 837-855. Final concept Paper.

Vaccines 52

Vaccines FDA 52

pharmaphorum

JANUARY 21, 2021

According to the 2012 European Health Literacy Survey , 29% to 62% of people across eight EU member states had inadequate or problematic health literacy. Those steps were followed in October with a new global policy that banned any adverts that would discourage people from getting vaccinated, whether for COVID, the flu or anything else. “We

Vaccines 111

Vaccines Packaging 111

The FDA Law Blog

FEBRUARY 4, 2025

This time, however, the program, which has helped incentivize the development of dozens of pediatric rare disease therapies since 2012, was not renewed. The Rare Pediatric Disease (RPD) Priority Review Voucher (PRV) was caught in the crosshair once again.

Vaccines 52

Vaccines FDA 52